|
Volumn 31, Issue 1-2, 1999, Pages 1029-1030
|
Reduction of reperfusion injury with prostacyclin I2 after liver transplantation
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
PROSTACYCLIN;
TACROLIMUS;
THROMBOXANE A2;
TUMOR NECROSIS FACTOR ALPHA;
ADULT;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG MECHANISM;
FEMALE;
GRAFT FAILURE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
LIVER TRANSPLANTATION;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REPERFUSION INJURY;
TISSUE OXYGENATION;
TREATMENT FAILURE;
TREATMENT OUTCOME;
ADULT;
ASPARTATE AMINOTRANSFERASES;
BLOOD TRANSFUSION;
EPOPROSTENOL;
FEMALE;
GRAFT SURVIVAL;
HUMANS;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
RECEPTORS, TUMOR NECROSIS FACTOR;
REPERFUSION INJURY;
|
EID: 0032985344
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)01888-0 Document Type: Conference Paper |
Times cited : (14)
|
References (13)
|